Hematologic Neoplasms Clinical Trials

109 clinical trials for Hematologic Neoplasms across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms — RECRUITING · PHASE1
• Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members — RECRUITING
• Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation — RECRUITING · PHASE1
• Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies — RECRUITING · PHASE1
• Influenza Vaccination Strategy for Patients With Hematologic Malignancy — RECRUITING · PHASE3
• A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies — RECRUITING · PHASE1
• Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT — RECRUITING · PHASE3
• Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies — RECRUITING · PHASE1
• Cognitive Training Intervention and Attitudes Towards Genetics — RECRUITING · NA
• LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) — RECRUITING · NA
• Mind-body Medicine for Patients With Malignant Hematological Diseases — RECRUITING · NA
• UWCCC Molecular Tumor Board Registry — RECRUITING
• Pre-myeloid Cancer and Bone Marrow Failure Clinic Study — RECRUITING · NA
• Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) — RECRUITING · PHASE3
• A Multi-center Investigation of Family Health. — RECRUITING
• Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation — RECRUITING · NA
• Prospective Validation of the OHI Index — RECRUITING
• Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion — ACTIVE_NOT_RECRUITING · NA
• Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers — NOT_YET_RECRUITING · PHASE2
• Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil — ACTIVE_NOT_RECRUITING · PHASE2
• Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients — NOT_YET_RECRUITING
• Take5Care+: A Self-management Educational Intervention — NOT_YET_RECRUITING · NA
• Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies — COMPLETED · PHASE1
• Optimizing PTCy Dose and Timing — ACTIVE_NOT_RECRUITING · PHASE1
• Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy — NOT_YET_RECRUITING
• Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients — COMPLETED · NA
• TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia — COMPLETED · PHASE3
• Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation — COMPLETED · PHASE2
• The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash — NOT_YET_RECRUITING · NA
• Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital — COMPLETED
• Early Palliative Care and Hematological Cancer Patients — TERMINATED · NA
• Therapeutic Education in Physical Activity (ETAF) — COMPLETED · NA
• A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies — COMPLETED · PHASE1
• Genomic Testing and Resulting Medical Decisions — COMPLETED
• Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey — COMPLETED
• Natural Killer Cell (CYNK-001) Infusions in Adults with AML — TERMINATED · PHASE1
• Evaluation of ClearLLab LS Screening Panel — COMPLETED
• RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL — COMPLETED · PHASE1
• CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL — COMPLETED · PHASE1
• Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) — COMPLETED · PHASE1
• A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System — TERMINATED · PHASE1
• Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation — COMPLETED · PHASE1
• CD155 Expression in Acute Myeloid Leukemia — COMPLETED
• Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy — WITHDRAWN
• Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients — OTHER · NA
• The ACC Preclinical Research Platform for Precision Oncology — OTHER
• A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms — COMPLETED · PHASE1
• Bleeding In Thrombocytopenia Explained — OTHER
• Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors — OTHER · PHASE2
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies — COMPLETED · PHASE1

Refine this search